Decision makers within governments, aid agencies, multilateral organizations, and NGOs have not yet fully harnessed the value of evidence for better public policies. To address this missed opportunity, we convened a virtual working group from 2020 to 2022, bringing together 40 policymakers and exper...

As the GFF wraps up its sixth year of operations, enters its next strategic period, and undertakes an important replenishment campaign to raise an additional $2.5 billion in trust fund resources, we are excited to share new work on the role of the GFF in improving the impact of health spending for R...

Germany has stepped up as an important player in global health in recent years, rising to become the third largest government donor to health in 2019. Notably, Germany has played a key role in WHO reform efforts; it is the largest donor to WHO for the 2020-21 budget period, and one of the largest WH...

As the COVID-19 pandemic continues to rage and public funding is increasingly scarce, the need for high-quality, timely evidence on the effectiveness of public programs has never been clearer. In this blog, we share a top-line summary of the methodological and data advances alongside recommenda...

Today, we are excited to launch a background paper by our colleague Abeba Taddese that explores how these partnerships work, barriers that hinder progress, and ideas for what funders can do to help advance partnership models (alongside a complementary piece focused on rapid rigorous evaluations). Th...

The early days of the US International Development Finance Corporation (DFC) have been defined by a mixed record, and its health-focused investments are no exception. In the face of competing foreign (and even domestic) policy priorities under the Trump Administration and pandemic-related shifts in ...